AlphAIalphai — Financial news for AI agents
tradingview.comJUL 311 min read$MED

MED Q2'26 Earnings: EPS estimate is (0.65) USD

Medifast Inc. (MED) is scheduled to report Q2 2026 earnings on Aug. 3 after the market closes, with results expected at 4:05 PM ET. The consensus estimates call for revenue of $72.70 million and EPS of -$0.65 for the quarter, according to the article.

Original reporting
tradingview.com
Published Jul 31, 2026, 11:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 9:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
MED Q2'26 Earnings: EPS estimate is (0.65) USD — source image
Source · tradingview.com
Decision brief

The 30-second read

$MEDNeutralMed
01

Why it matters

Traders can use the consensus revenue ($72.70M) and EPS (-$0.65) to frame expectations and manage event risk into the after-hours release.

02

Market read

The article is a scheduled earnings preview with consensus estimates, useful for event-risk positioning ahead of the print.

03

What to watch

Actual results could hinge on margin and subscriber retention trends, which are not discussed in the article, so consensus alone may not capture the key drivers.

Relevance 5/10Novelty 5/10Timing: ahead of Aug 03 after-hours earnings release

Background

MEDIFAST (MED) is set to announce Q2'26 earnings on Aug 03 after the market closes.

Company-level read

Ticker impact

$MEDNeutralLow confidence
Context

MEDIFAST is scheduled to report Q2'26 results Aug 03 after the close, with consensus revenue of $72.70M and EPS of -$0.65.

Expected impact

Likely volatility around the Aug 03 after-hours earnings release versus the -$0.65 EPS and $72.70M revenue expectations.

Evidence & confidence

The article provides only the scheduled earnings date and consensus estimates, with no new guidance, results, or surprises disclosed yet.

Market effects

Sector

Limited spillover; this is company-specific pre-earnings positioning for a diet/weight-management retailer.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

If the company has a history of beating or guiding conservatively, the negative EPS consensus may already be priced in, reducing incremental downside risk.

Key entities

  • public_company
    MED

    MEDIFAST Inc., scheduled to report Q2'26 results on Aug 03 after the close.

Read at source← All news

Related articles

AUG 4
$MEDHighAI 9/10

Why Medifast (MED) Stock Is Trading Up Today

Medifast (NYSE: MED) shares rose 37.5% after Q2 results beat expectations and the company issued a stronger full-year outlook. Medifast reported a $0.28 per-share loss versus a $0.65 expected loss, and revenue of $76.38 million. It guided full-year GAAP EPS of $1.00 at the midpoint, versus analyst estimates.

financialcontent.com4 min
AUG 8
$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

yahoo.com6 min
AUG 8
$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.

yahoo.com6 min
AUG 8
$KOPMed

Koppers Q2 Earnings Call Highlights

Koppers (NYSE:KOP) reported Q2 updates on capital spending of about $24M, shareholder returns of $47M, and debt reduction of $22M in the first half. Liquidity was $390M with net debt of $857M and net leverage at 3.5x. The board raised its dividend to $0.09/share. KOP kept 2026 sales guidance at $1.9B-$2.0B but cut adjusted EBITDA to $240M-$250M and EPS to $3.80-$4.20.

yahoo.com6 min
AUG 8
$KNTKMed

Kinetik Q2 Earnings Call Highlights

Kinetik (NYSE:KNTK) Q2 earnings call said Waha pricing normalization and faster curtailment return, higher WTI and liquids assumptions, and system operating improvements supported a revised outlook. It raised 2026 capex to about $560M, expects Q3 Adjusted EBITDA $260M-$270M and Q4 $270M-$280M, and lifted 2026 volume growth to mid- to high-single digits.

yahoo.com6 min